Back
Corbus Pharmaceuticals Holdings Stock Predictions

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
40
CRBP
Corbus Pharmaceuticals Holdings
Last Price:
$8.18
Seasonality Move:
-5.39%
7 Day Trial
ALL ACCESS PASS
$
7

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compaCorbus Pharmaceuticals Holdings Stock Forecast
-
Over the next 52 weeks, Corbus Pharmaceuticals Holdings has on average historically risen by 35.5% based on the past 10 years of stock performance.
-
Corbus Pharmaceuticals Holdings has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Corbus Pharmaceuticals Holdings Stock Undervalued?The current Corbus Pharmaceuticals Holdings [CRBP] share price is $8.31. The Score for CRBP is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
CRBP is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Corbus Pharmaceuticals Holdings Stock Go Up Next Year?
-
Over the next 52 weeks, Corbus Pharmaceuticals Holdings has on average historically risen by 35.5% based on the past 10 years of stock performance.
Corbus Pharmaceuticals Holdings Stock Rating
Sell
40
Corbus Pharmaceuticals Holdings (CRBP)
is a Sell
Is Corbus Pharmaceuticals Holdings overpriced?
-
Corbus Pharmaceuticals Holdings has risen higher in 5 of those 10 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Corbus Pharmaceuticals Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
corbuspharma.com
52-Week Data
52-Week High:
61.90
52-Week Low:
4.64
Prediction Charts
Market Cap:
101.7M
Price in USD:
8.31
Volume:
68.1K
Beta:
2.40
Technical Analysis
SMA50:
7.40
SMA100:
7.52
SMA200:
15.13
52-Wk Change:
-81.03%
Stock Predictions
-
Is Corbus Pharmaceuticals Holdings stock public?Yes, Corbus Pharmaceuticals Holdings is a publicly traded company.
-
What is the Corbus Pharmaceuticals Holdings stock quote today?The Corbus Pharmaceuticals Holdings stock price is 8.31 USD today.
-
How to buy Corbus Pharmaceuticals Holdings stock online?You can buy Corbus Pharmaceuticals Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
May-30 | 7.58 | 7.42 | 7.58 | 7.18 |
Jun-2 | 7.46 | 7.34 | 7.56 | 7.05 |
Jun-3 | 7.40 | 8.30 | 8.36 | 7.22 |
Jun-4 | 8.29 | 8.47 | 8.53 | 8.02 |
Jun-5 | 8.51 | 8.80 | 8.85 | 8.10 |
Jun-6 | 8.99 | 9.23 | 9.35 | 8.90 |
Jun-9 | 9.24 | 9.21 | 9.45 | 8.86 |
Jun-10 | 9.26 | 9.24 | 9.40 | 9.02 |
Jun-11 | 9.30 | 8.97 | 9.39 | 8.97 |
Jun-12 | 8.90 | 9.17 | 9.28 | 8.56 |
Jun-13 | 8.98 | 8.83 | 9.16 | 8.80 |
Jun-16 | 8.87 | 8.74 | 9.14 | 8.62 |
Jun-17 | 8.70 | 8.28 | 8.71 | 8.28 |
Jun-18 | 8.28 | 8.31 | 8.47 | 8.10 |
Corbus Pharmaceuticals Holdings Earnings
Corbus Pharmaceuticals Holdings Earnings Report: Per Share Corbus Pharmaceuticals Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.
Corbus Pharmaceuticals Holdings Forecast Revenue Growth
Corbus Pharmaceuticals Holdings Stock Analysis: Historical quarterly revenues per share for Corbus Pharmaceuticals Holdings and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.41 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.93 per share, and an increase next year of $0.46 per share.
* Corbus Pharmaceuticals Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.